secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001171843-22-007386
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology Q3 revenue $455.8K (+45% YoY); appoints new CEO Raymond Vennare
--------------------------------------------------------------------------------

- Q3 revenue $455,827, up 45% from $313,663 in Q3 2021; gross margin improved to 76% from 65%.
- Net loss for nine months $17.8M vs $11.9M year ago, including $7.2M goodwill impairment for zPREDICTA.
- Raymond F. Vennare appointed CEO and Chairman; he has 30+ years biotech experience.
- R&D expenses down 50% to $116,763; G&A up to $3.29M due to acquisition and CEO retirement costs.
- Cash and equivalents $25.4M at Sept 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184322007386/0001171843-22-007386-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184322007386/f8k_111022.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-007386

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer